Traditional imaging modalities and tumor markers, such as carcinoembryonic antigen (CEA), squamous cell carcinoma (SCC) antigen, Cytokeratin 19 Fragment Antigen 21‐1 (CYFRA21‐1), exhibit limited sensitivity and are often delayed in predicting recurrence. Here, SERPINB3 is linked to neoplasm.